Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 223

Similar articles for PubMed (Select 11557835)

1.

Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.

Gadde KM, Parker CB, Maner LG, Wagner HR 2nd, Logue EJ, Drezner MK, Krishnan KR.

Obes Res. 2001 Sep;9(9):544-51.

PMID:
11557835
2.

Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.

Jain AK, Kaplan RA, Gadde KM, Wadden TA, Allison DB, Brewer ER, Leadbetter RA, Richard N, Haight B, Jamerson BD, Buaron KS, Metz A.

Obes Res. 2002 Oct;10(10):1049-56.

PMID:
12376586
3.

Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.

Anderson JW, Greenway FL, Fujioka K, Gadde KM, McKenney J, O'Neil PM.

Obes Res. 2002 Jul;10(7):633-41.

PMID:
12105285
4.

Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study.

Gadde KM, Yonish GM, Foust MS, Wagner HR.

J Clin Psychiatry. 2007 Aug;68(8):1226-9.

PMID:
17854247
5.

Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.

Gadde KM, Yonish GM, Wagner HR 2nd, Foust MS, Allison DB.

Int J Obes (Lond). 2006 Jul;30(7):1138-42. Epub 2006 Jan 17.

PMID:
16418753
6.

Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.

Kopelman P, Bryson A, Hickling R, Rissanen A, Rossner S, Toubro S, Valensi P.

Int J Obes (Lond). 2007 Mar;31(3):494-9. Epub 2006 Sep 5.

PMID:
16953261
7.

Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.

Zelissen PM, Stenlof K, Lean ME, Fogteloo J, Keulen ET, Wilding J, Finer N, Rössner S, Lawrence E, Fletcher C, McCamish M; Author Group.

Diabetes Obes Metab. 2005 Nov;7(6):755-61.

PMID:
16219020
8.

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.

Halpern A, Mancini MC, Suplicy H, Zanella MT, Repetto G, Gross J, Jadzinsky M, Barranco J, Aschner P, Ramirez L, Matos AG.

Diabetes Obes Metab. 2003 May;5(3):180-8.

PMID:
12681025
9.

X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.

Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, Zanella MT, Zúñiga-Guajardo S, Van Gaal L.

Diabetes Obes Metab. 2005 Nov;7(6):699-708.

PMID:
16219013
11.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
12.

Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.

Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.

Clin Ther. 2004 Sep;26(9):1427-35.

PMID:
15531005
13.

Zonisamide for weight loss in obese adults: a randomized controlled trial.

Gadde KM, Franciscy DM, Wagner HR 2nd, Krishnan KR.

JAMA. 2003 Apr 9;289(14):1820-5.

PMID:
12684361
14.
15.

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E; COR-I Study Group.

Lancet. 2010 Aug 21;376(9741):595-605. doi: 10.1016/S0140-6736(10)60888-4. Epub 2010 Jul 29. Erratum in: Lancet. 2010 Aug 21;376(9741):594. Lancet. 2010 Oct 23;376(9750):1392.

PMID:
20673995
17.

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II).

Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, Kim D, Dunayevich E; COR-II Study Group.

Obesity (Silver Spring). 2013 May;21(5):935-43. doi: 10.1002/oby.20309.

18.

Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial.

White MA, Grilo CM.

J Clin Psychiatry. 2013 Apr;74(4):400-6. doi: 10.4088/JCP.12m08071.

19.

Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week randomized, double-blind, placebo-controlled trial.

Joffe G, Takala P, Tchoukhine E, Hakko H, Raidma M, Putkonen H, Eronen M, Räsänen P.

J Clin Psychiatry. 2008 May;69(5):706-11.

PMID:
18426261
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk